Risk factors for failure of antibiotic therapy for tubo-ovarian abscess

Authors

  • Yau-Chung LI
  • Ting-Fung MA

DOI:

https://doi.org/10.12809/hkjgom.19.1.01

Keywords:

Abscess, Anti-bacterial agents, Drainage, Fallopian tube diseases, Ovarian diseases

Abstract

Objective: To assess the risk factors for antibiotic therapy failure and to predict which patients will require surgical drainage for tubo-ovarian abscess.
Methods: We collected data from patients by ICD-9 codes starting with 614.2. We extracted data regarding background information, clinical presentation, laboratory parameters, and ultrasonographic findings. Patients responded to antibiotics alone were compared with patients required surgical drainage. Relative risk of surgical drainage was estimated with logistic regression model.
Result: A total of 126 cases of tubo-ovarian abscess were evaluated, of which 92 were successfully managed with antibiotic therapy alone and 34 required surgical drainage. Age, multiparity, intrauterine device use, fever, maximal white cell count and abscess size were identified to be significant risk factors associated with the need for surgical drainage. The adjusted relative risks of surgical drainage were 2.250 for abscess size ≥8 cm, and 3.162 for fever on admission. The duration of hospitalisation was increased by 23.8% for abscess size ≥8 cm and by 23.7% for fever
on admission.
Conclusion: Larger abscesses are associated with increased risk of surgical drainage. However, additional research is required to determine the optimal treatment for large abscesses. It is reasonable to try antibiotic therapy in clinically stable patients irrespective of abscess size.

References

Pedowitz P, Bloomfield RD. Ruptured adnexal abscess (tuboovarian) with generalized peritonitis. Am J Obstet Gynecol 1964;88:721-9.

Martens MG. Pelvic inflammatory disease. In: Rock JA, Thompson JD, editors. Te Linde’s Operative Gynaecology. 9th ed. Philadelphia: Lippincott Williams and Wilkins; 2003.

Munro K, Gharaibeh A, Nagabushanam S, Martin C. Diagnosis and management of tubo-ovarian abscesses. Obstet Gynaecol 2018;20:11-9.

Chappell CA, Wiesenfeld HC. Pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and tubo ovarian

abscess. Clin Obstet Gynecol 2012;55:893-903.

Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280:1690-1.

Greenstein Y, Shah AJ, Vragovic O, et al. Tuboovarian abscess. Factors associated with operative intervention after failed antibiotic therapy. J Reprod Med 2013;58:101-6.

Akkurt MÖ, Yalçın SE, Akkurt I, et al. The evaluation of risk factors for failed response to conservative treatment in tubo ovarian abscesses. J Turk Ger Gynecol Assoc 2015;16:226-30.

Dewitt J, Reining A, Allsworth JE, Peipert JF. Tuboovarian abscesses: is size associated with duration of hospitalization & complications? Obstet Gynecol Int 2010;2010:847041.

Crespo FA, Ganesh D, Lo K, et al. Surgical, ultrasound guided drainage, and medical management of tuboovarian abscesses. ISRN Infect Dis 2014;2014:501729.

Downloads

Published

2023-04-06

How to Cite

1.
LI Y-C, MA T-F. Risk factors for failure of antibiotic therapy for tubo-ovarian abscess. Hong Kong J Gynaecol Obstet Midwifery [Internet]. 2023 Apr. 6 [cited 2024 Nov. 21];19(1). Available from: https://hkjgom.org/home/article/view/258

Issue

Section

Original Article